Commentary|Podcasts|June 21, 2024
Navigating Market Access Hurdles
Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.
Advertisement
In this exclusive PC Podcast interview, Mark Bouck, chairman and CEO of PharmAlliance, a pharmaceutical and life sciences services platform, dives into:
- How PharmAlliance’s acquisition of Complete Health Economics Outcomes Research Solutions (CHEORS) helps expand global reach
- The platform’s biggest goal to when it comes to CHEORS and market access services
- How CHEORS helps navigate cost-effectiveness and market access hurdles
- Acquisitions in the space that are currently in the works
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the US Section 301 Probe Targets Germany's Drug Pricing
2
Why Packaging Is Now a Frontline Issue In Pharma Supply Chains
3
Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?
4
Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027
5